Navigation Links
Hope for transplant patients as study finds key to organ scarring
Date:11/10/2013

Patients with damaged organs could be helped by new treatments after scientists have discovered how tissues scar.

Researchers say that the finding could pave the way for new drugs and eventually reduce the number of patients on organ transplant waiting lists.

Fibrotic diseases occur in many tissues within the body including the liver, lung or kidneys and have a range of causes including viruses or toxins. Experts say that the main source of scar tissue is found in specialised cells called Myofibroblasts.

The study discovered that a molecule on these cells is a key regulator of fibrotic disease.

Scientists say that the molecule called alpha v integrin is a critical switch involved in turning on the myofibroblast cells to make scar tissue.

The team studied specially bred mice with fibrosis to see if removing the alpha v integrin molecule on myofibroblasts would reduce the amount of scar tissue in their organs.

Researchers found that when they removed alpha v integrin from these cells, the mice were protected from fibrosis of the liver, lung and kidneys.

They also found that when they treated the mice with a new experimental drug designed to block alpha v integrins, the animals were protected from liver and lung fibrosis.

Dr Neil Henderson, a Wellcome Trust clinical scientist and consultant hepatologist at the University of Edinburgh / MRC Centre for Inflammation Research, said: "When tissue scarring becomes severe, affected organs do not work properly and currently the only treatment for end-stage organ failure is transplantation. However the shortage of donor organs means that many patients die while waiting for surgery.

"Therefore, the development of new therapies to treat fibrosis and reduce the need for organ transplantation would potentially be a major step forward in the treatment of patients with these devastating diseases."


'/>"/>

Contact: Eleanor Cowie
eleanor.cowie@ed.ac.uk
44-131-650-6382
University of Edinburgh
Source:Eurekalert

Page: 1

Related medicine news :

1. Discovery could help to develop drugs for organ transplant and cancer patients
2. Xenotransplantation as a therapy for type 1 diabetes
3. First, Second Kidney Transplants Have Similar Success: Study
4. Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
5. Statins prevent cancer in heart transplant recipients
6. U.S. Liver Transplants Declining
7. Study shows antibiotic improves respiratory function in lung transplant patients
8. UCLA launches first face transplantation program in western US
9. Use of Smokers Lungs for Transplant Has Pros, Cons
10. Skin transplant offers new hope for vitiligo patients
11. Haematopoietic stem cell transplantation increases survival in systemic sclerosis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, ... (iPS) cells and other difficult to transfect cells, announces its launch of the ... G9™ Gene Editing System is a complete system for culturing and transfecting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: